Auransa was founded by Pek Lum.

Who are Auransa's investors?

Auransa's investors include 11.2 Capital, DCVC (Data Collective), Harmonix Fund, Lux Capital.

Auransa

11 employees on LinkedIn · 4 known investors

Find your way into Auransa

172 people in our graph share verified history with the Auransa team — schools, employers, funds. One of them is your warm intro.

Dana Settleunlockedknows Pek Lum · together at University of Washington (overlapped)

×8knows the team · via Rosetta/Merck

×2knows the team · via University of Washington

knows the team · via Hokkaido University

Auransa is a clinical-stage, AI-native biopharma company that analyzes large human disease datasets to discover and develop novel cancer therapies. It works collaboratively with pharmaceutical companies and academic institutions to advance its drug discovery programs.

AI & Machine Learning Biotech Healthtech

Founders & leadership

Pek Lum inCo-Founder & CEOPek Lum was an early employee at Rosetta, a genomics technology company acquired by Merck, where he worked on integrating data science into drug discovery. He is now co-founder and CEO of Auransa, a clinical-stage biopharma company developing AI-powered cancer therapies.

Investors · 4

11.2 CapitalLas Vegas · $500K – $3M

DCVC (Data Collective)Palo Alto · $5M – $25M

Harmonix FundLa Quinta

Lux CapitalNew York · $100K – $100M

Frequently asked questions

What does Auransa do?: Auransa is a clinical-stage, AI-native biopharma company that analyzes large human disease datasets to discover and develop novel cancer therapies. It works collaboratively with pharmaceutical companies and academic institutions to advance its drug discovery programs.
Who founded Auransa?: Auransa was founded by Pek Lum.
Who are Auransa's investors?: Auransa's investors include 11.2 Capital, DCVC (Data Collective), Harmonix Fund, Lux Capital.